Parallax Volatility Advisers’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Parallax Volatility Advisers’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-31,000	Closed	-$1.66M	–	4379
2016 Q1	$1.66M	Buy	31,000 +29	+0.1%	+$2.14K	﹤0.01%	982
2015 Q4	$3.5M	Sell	30,971 -200	-0.6%	-$22K	0.01%	816
2015 Q3	$3.67M	Buy	31,171 +28,179	+942%	+$3.68M	0.01%	778
2015 Q2	$232K	Buy	+2,992	New	+$196K	﹤0.01%	1927

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Parallax Volatility Advisers's ANAC Position: Q2 2016 in Review

Parallax Volatility Advisers sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 31,000 shares — an estimated $1.66M sold.

Parallax Volatility Advisers first reported a position in ANAC in Q2 2015 and held it in 4 quarters. The position peaked at $3.67M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Parallax Volatility Advisers reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Parallax Volatility Advisers sold 31,000 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.66M.
Parallax Volatility Advisers first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 4 quarters.
Parallax Volatility Advisers's ANACOR PHARMACEUTICALS INC COM position peaked at $3.67M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Parallax Volatility Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.